The abstract is read at the publisher; the summary is JClub's.
Resection-margin–guided antimicrobial tailoring for diabetic foot osteomyelitis is conceptually appealing but remains ill-defined and inconsistently measured, undermining bedside reliability.
- Why it matters: Updated guidelines shift toward individualized therapy, yet the “clean margin” construct lacks clear operationalization and prospective validation, leaving uncertainty about how to interpret residual infection.
- What they did: The concept evolved from descriptive residual infected bone assessments to categorical “positive” versus “negative” margins, drawing on limited trial data with uncertain ascertainment and variable measurement across surgical, histopathological, and microbiological domains.
- The result: Because these margin assessments are not interchangeable and are often discordant, routine implementation is premature; standardized definitions and prospective validation are needed to support reliable treatment decisions.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.